Form 4 for AORT ARTIVION, INC.
Accepted 2025-05-12 00:00:00 ET · period of report 2025-05-09 · accession 0000784199-25-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-12 | 2025-05-09 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $29.13 | -10.5K | 110.1K | -9% | -$307.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-09 | S | D | 4,811 | $29.13 | 105,332 | D | — | — | (F2) Reflects weighted average price for Performance Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-05-09 | S | D | 5,737 | $29.13 | 110,143 | D | — | — | (F1) Reflects weighted average price for Restricted Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |